Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury
B. Rohaut,C. Calligaris,B. Hermann,P. Perez,F. Faugeras,F. Raimondo,J-.R. King,D. Engemann,C. Marois,L. Le Guennec,L. Di Meglio,A. Sangaré,E. Munoz Musat,M. Valente,A. Ben Salah,A. Demertzi,L. Belloli,D. Manasova,L. Jodaitis,M. O. Habert,V. Lambrecq,N. Pyatigorskaya,D. Galanaud,L. Puybasset,N. Weiss,S. Demeret,F. X. Lejeune,J. D. Sitt,L. Naccache
DOI: https://doi.org/10.1038/s41591-024-03019-1
IF: 82.9
2024-05-31
Nature Medicine
Abstract:Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of behavioral, neuroimaging and electrophysiological markers affects the performance of outcome predictions. We analyzed data from 349 patients admitted to a tertiary neurointensive care unit between 2009 and 2021, categorizing prognoses as good, uncertain or poor, and compared these predictions with observed outcomes using the Glasgow Outcome Scale–Extended (GOS-E, levels ranging from 1 to 8, with higher levels indicating better outcomes). After excluding cases with life-sustaining therapy withdrawal to mitigate the self-fulfilling prophecy bias, our findings reveal that a good prognosis, compared with a poor or uncertain one, is associated with better one-year functional outcomes (common odds ratio (95% CI) for higher GOS-E: OR = 14.57 (5.70–40.32), P < 0.001; and 2.9 (1.56–5.45), P < 0.001, respectively). Moreover, increasing the number of assessment modalities decreased uncertainty (OR = 0.35 (0.21–0.59), P < 0.001) and improved prognostic accuracy (OR = 2.72 (1.18–6.47), P = 0.011). Our results underscore the value of multimodal assessment in refining neuroprognostic precision, thereby offering a robust foundation for clinical decision-making processes for acutely brain-injured patients. ClinicalTrials.gov registration: NCT04534777.
biochemistry & molecular biology,cell biology,medicine, research & experimental